Abstract Treatment of brain injury with exosomes derived from mesenchymal stromal cells (MSCs) enhances neurite growth. However, the direct effect of exosomes on axonal growth and molecular mechanisms underlying exosomeenhanced neurite growth are not known. Using primary cortical neurons cultured in a microfluidic device, we found that MSC-exosomes promoted axonal growth, whereas attenuation of argonaut 2 protein, one of the primary microRNA (miRNA) machinery proteins, in MSC-exosomes abolished their effect on axonal growth. Both neuronal cell bodies and axons internalized MSC-exosomes, which was blocked by botulinum neurotoxins (BoNTs) that cleave proteins of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Moreover, tailored MSCexosomes carrying elevated miR-17-92 cluster further enhanced axonal growth compared to native MSC-exosomes. Quantitative RT-PCR and Western blot analysis showed that the tailored MSC-exosomes increased levels of individual members of this cluster and activated the PTEN/mTOR signaling pathway in recipient neurons, respectively. Together, our data demonstrate that native MSC-exosomes promote axonal growth while the tailored MSC-exosomes can further boost this effect and that tailored exosomes can deliver their selective cargo miRNAs into and activate their target signals in recipient neurons. Neuronal internalization of MSCexosomes is mediated by the SNARE complex. This study reveals molecular mechanisms that contribute to MSCexosome-promoted axonal growth, which provides a potential therapeutic strategy to enhance axonal growth.
Introduction
Axonal remodeling is a key repair process, leading to reduction of neurological deficits after stroke and traumatic brain injury (TBI). However, spontaneous axonal regeneration is limited in adult injured brain [1] [2] [3] . There are two major conditions that limit neurite regrowth after brain injury, a diminished intrinsic capacity of the neurons to grow and an inhibitory extrinsic environment [4] [5] [6] [7] . However, several lines of evidence indicate that axons can sprout after injury in adult central nervous system [8] [9] [10] [11] [12] . Recent studies show that distal axons of embryonic cortical neurons contain microRNA (miRNA) machinery proteins, Dicer and argonaut 2 (Ago2) proteins, and are enriched with miRNAs that can locally regulate axonal growth [13] [14] [15] . For example, alteration of the miR-17-92 cluster and miR-29c levels in the cultured neurons promote axonal growth by suppressing their target genes that inhibit axonal growth even under the inhibitory environment with chondroitin sulfate proteoglycans [16, 17] .
Exosomes are endosome-derived small membrane vesicles (∼30-100 nm) and are released by cells in all living systems [18, 19] . Exosomes mediate intercellular communication by transferring proteins, lipids, and genomic materials including mRNAs and miRNAs between source and target cells [20] . Emerging data indicate that treatment of stroke and TBI with exosomes derived from MSCs improves neurological function by facilitating interwoven brain repair processes including neurite remodeling [21] [22] [23] . In vitro studies indicate that miR133b in MSC-exosomes mediate neurite growth of cortical neurons [24] . However, mechanisms underlying the effect of MSC-exosomes on axonal growth remain unknown. Using embryonic cortical neurons cultured in a microfluidic device, we investigated whether MSC-exosomes deliver their cargo miRNAs into recipient neurons and promote axonal growth. Our data demonstrated that miRNAs within MSC-exosomes mediated axonal growth and that tailored MSC-exosomes carrying elevated miR-17-92 cluster enhanced axonal growth to a much greater extent than native MSC-exosomes.
Material and Methods
All experimental procedures were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of Henry Ford Hospital.
Neuronal Culture in a Microfluidic Device
Cortical neurons were harvested from embryonic day-18 Wistar rats (Charles River Laboratories, Wilmington, MA) according to the published protocol [25] . Cultures were prepared according to published studies with some modifications [16, 26] . Briefly, the isolated cortical neurons were prepurified by density gradient separation to remove astrocytes, oligodendrocytes, and microglia [27] with the purity of more than 95 % as reported [28] . The cortical neurons were then seeded in a microfluidic culture device (Standard Neuron Device, Cat# SND450, Xona Microfluidics, Temecula, CA) at density at 3 × 10 7 cells/ml (∼3 × 10 5 cells in the somal compartment). The microfluidic culture device permits distal axons to grow into the axonal compartment after passing 450-μm-long microgrooves that connect the cell body and axonal compartments [26] . The application of exosomes was performed on days in vitro 3 (DIV3), when all of the microgrooves were fully filled with axons. Distal axonal length was imaged in the axonal compartment 24 and 48 h after exosomal application, and at least 15 longest axons per device were analyzed according to our published protocol [16, 17] .
Time-Lapse Microscopy to Track Axonal Growth
Primary cortical neurons cultured in a microfluidic device were incubated on a stage top chamber with 5 % CO2 at 37°C (LiveCell Control Unit), which was placed on the stage of a TE2000-U inverted microscope equipped with a motorized z-stage (Nikon, Tokyo, Japan). To track axonal growth, a ×20 objective with ×1.5 zoom was used for acquiring images in the axonal compartment. A stack of images (ten images of 1 μm steps of the z-axis) was acquired under a bright-field view at 5-min intervals for a total of 60 min using a CCD camera (CoolSnap, 5000) controlled by a Metamoph software (Universal Imaging, West Chester, PA) [29] . Four to five individual distal axons with healthy growth cones were imaged and approximately 40 growth cones per experimental group were recorded.
Isolation of MSC-Exosomes
Rat primary MSCs were harvested and cultured from the bone marrow of adult Wistar rats (Charles River Laboratories, Wilmington, MA) [24] . Passage 1 MSCs were employed to generate exosomes [21, 24] . Briefly, the supernatant of MSCs cultured in exosome-depleted growth medium was collected and filtered through a 0.22-μm filter (Millipore, CA) to sieve out dead cell and large growth debris. To remove additional debris, the filtered supernatant was run at a 10,000×g for 30 min. Ultracentrifugation was then performed at a 100, 000×g for 3 h to collect the exosomes. After that, the supernatant was collected and used for a negative control, whereas the pellet was diluted by sterilized PBS for further characterization and for use of experiments. Numbers and sizes of particles in the pellet were measured and analyzed by means of the qNano® system (IZON, UK).
MSC-Exosome Labeling
To track internalization of MSC-exosomes, the fresh harvested exosomes were transfected with Texas-red labeled siRNA by means of an exo-fect exosome transfection kit (System Bioscience). Briefly, 3 × 10 11 exosomes were incubated with tranfection solution and siRNA at 37°C in a shaker for 10 min and then exosome samples were placed on ice for 30 min to stop the reaction. Transfected exosomes were collected by 13, 000-rpm centrifugation for 30 min and resuspended by 100 μl PBS. These exosomes were immediately applied to the neurons cultured in a microfluidic device.
Generation of Tailored MSC Exosomes
The majority of miRNAs in exosomes are bounded to Ago2 [30, 31] . To examine whether Ago2 is required for the effect of exosomes on axonal growth, we generated MSC-exosomes with reduced Ago2. Briefly, MSCs were transfected with siRNA against Ago2 (GE Dharmacon, siGENOME Ago2 siRNA, M-094504-01) or scramble control (GE Dharmacon, siGENOME Non-Targeting Control siRNAs, D-001210-01) by means of electroporation [16] . Exosomes were isolated from the supernatant of these transfected MSCs cultured in exosome-depleted medium as aforementioned. Western blot analysis was performed to measure Ago2 levels in MSCs and MSC-exosomes. To generate tailored MSC-exosomes carrying elevated miR-17-92 cluster, MSCs were transfected with a miR-17-92 cluster plasmid (pCAG-GFP-miR-17-92) or an empty vector according to our published protocol [16] .
Exosomes were harvested from MSCs 72 h after transfection. Quantitative RT-PCR was performed to measure individual members of the cluster in exosomes.
Experimental Groups
To examine the role of MSC-exosomes on axonal growth, we placed 3 × 10 9 MSC-exosome into the somal compartment (diluted in 300 μl of growth medium) of the microfluidic culture device. In order to test the function of MSC-exosomes to locally promote axonal growth, we applied 3 × 10 8 (diluted in 300 μl of growth medium) MSC-exosomes into the axonal compartment. An equal amount of PBS employed for the dilution of exosomes was used as a control group.
To examine whether the SNARE complex is involved in MSC-exosome internalization by neurons, we employed two BoNTs, α-bungarotoxin (BoNT/A, Sigma-Aldrich, T0195) for the cleavage of Synaptosomal-Associated Protein 25 (SNAP25) and β-bungarotoxin (BoNT/B, Santa Cruz, 12778-32-4) for cleavage of vesicle associated membrane protein 2 (VAMP2) [32, 33] . Briefly, for the cleavage of neuronal SNAP25, BoNT/ A at 100 and 500 nM was applied to axonal and somal compartments, respectively, on DIV2, prior to the exosome treatment. For the cleavage of VAMP2 in exosomes, BoNT/B (200 nM) was applied to MSC-exosomes for 4 h. Then, these exosomes were placed into the axonal or soma compartment.
To examine the effect of MSC-exosomes on axons under chondroitin sulfate proteoglycan (CSPG) conditions, 2 μg/ml CSPGs (EMD Millipore, CC117) were applied into the axonal compartment of the microfluidic device on DIV2. Twenty-four hours later, the MSC-exosomes were added into either the somal compartment or axonal compartment, respectively, in the presence of CSPGs.
Endocytosis Assay
On DIV3, FM 1-43 FX (10 μM, F-35355, Life Technology) were added into the axonal compartment where axons had been treated with BoNT/A on DIV2 or without the BoNT/A treatment. Twenty minutes later, axons and their parent neuronal somata were then fixed with 4 % PFA for 10 min, washed with PBS three times. FM 1-43 FX signals in axonal compartments were imaged at 633-nm wavelength by means of confocal microscope (Zeiss LSM 510 NLO, Carl Zeiss, Germany) according to published protocol [34] .
Immunocytochemistry
Immunofluorescent staining was performed as previously described [17, 23, 35] Briefly, after washing with PBS twice and fixation with 4 % formaldehyde, axons and neurons in the microfluidic devices were incubated with the primary antibodies for one or two nights at 4°C, and then with Cy3 or FITCconjugated secondary antibodies for 2 h at room temperature. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI, 1:10,000, Vector Laboratories, Burlingame, CA). The following primary antibodies were used: a monoclonal antibody against phosphorylated neurofilament heavy chain (pNFH, SMI31, 1:500 Covance); a monoclonal antibody against microtubule-associated protein 2 (MAP2, MAB3418, 1:500 Chemicon).
Image Acquisition and Quantification
For measurements of axonal elongation after exosome treatment, the distal axons in the axonal compartment were imaged under a ×10 objective of an IX71 microscope (OLYMPUS, Tokyo, Japan) using a CCD camera (CoolSnap, 5000) and MetaView software (Universal Imaging, West Chester, PA). Five images per compartment were acquired, which encompassed the majority of the compartment. The lengths of the 15 longest axons in each compartment were measured by tracing individual axons with ImageJ according to the published procedures and data are presented as the average length of axons (mean ± SEM, μm) [36] .
For analysis of time-lapse images, extension of growth cones (n = ∼40) was acquired from six individual chambers of each experimental group and the extension of growth cones during the experimental period was measured and calculated with Metamorph software (Universal Imaging, West Chester, PA) and data are presented as extension length (mean ± SEM, μm).
For detection of labeled MSC-exosomes and FM 1-43 FX signals in cortical neurons, the cell bodies and axons of the cortical neurons were imaged under a ×63 objective after the immunocytochemistry staining using a laser-scanning confocal microscope (Zeiss LSM 510 NLO, Carl Zeiss, Germany) with three laser sources of 488, 543, and 633 nm [16, 29] . The images were captured and processed by laser scanning microscope LSM510 (Carl Zeiss, Germany, version 4.2 SP1).
Isolation of Proteins and RNAs from Axons
The axonal proteins or RNAs were harvested according to published studies [16, 17] . Briefly, the growth medium in the axonal compartment was collected, whereas the medium in soma compartment was retained to avoid the backflow of lysis buffer to the soma compartment. The axonalcompartment was rinsed two times with PBS and then 10 μl of lysis buffer (RIPA for protein harvesting and Qiazol for RNAs, respectively) was added into the axonal compartment for 10 min on ice. The lysate was then collected and reused for an additional microfluidic device in order to concentrate the axonal proteins [17] . For extraction of total RNAs in the axonal compartment, Qiazol lysis buffer was used.
Western Blot Analysis
Protein concentration of the lysate of the cell body and axonal extracts was determined using a bicinchoninic acid (BCA) protein assay kit (Pierce Biotechnology, Rockford, IL). Western blots were performed according to published methods [16] . Briefly, equal amounts of total protein for each sample were loaded on 10 % SDS-polyacrylamide gels. After electrophoresis, the protein was transferred to PVDF membranes and the blots were subsequently probed with the following primary antibodies: rabbit polyclonal anti-SNAP-25 (1:500; ab5666, Abcam, corresponding to SNAP-25 AA 195-206, which is cleaved out by BoNT/A.), mouse momoclonal anti-VAMP2 (1:500; ab90433, corresponding to VAMP2 AA 33-96), rabbit polyclonal anti-phosphatase and tensin homolog (PTEN, 1:1000; Cell Signaling Technology), rabbit polyclonal antiphosphorylated mechanistic target of rapamycin (mTOR, Ser 2448, 1:1000; Cell Signaling Technology), rabbit polyclonal anti-phosphorylated glycogen synthase kinase 3β (GSK-3β, Ser 21/9, 1:1000; Cell Signaling Technology), rabbit polyclonal anti-PI3 kinase p85 (1:1000; Millipore), rabbit polyclonal anti-Ras homolog gene family, member A (RhoA, 1:1000; ProteinTech), and mouse monoclonal anti β-actin (1:10,000; Abcam, Cambridge, MA). For detection, horseradish peroxidase-conjugated secondary antibodies were used (1:2000) followed by enhanced chemiluminescence development (Pierce Biotechnology). Protein levels of β-actin and PI3K subunit p85 were used as the internal controls for somata and axons, respectively [37] . Western blots were performed from at least three individual experiments. The optical density of protein signals was quantified using an image processing and analysis program (Scion Image, Ederick, MA).
Total proteins from MSC-exosomes were collected using 2× lysis buffer (RIPA, sigma) to lyse exosome samples. The (e) from the control (Ctl) and MSC-exosome (Exo) groups when the exosomes were applied into the soma compartment for 24 and 48 h. * p < 0.001 vs control. f, g Representative time-lapse microscopic images of the growth cone extension (f) and quantitative data of growth cone elongation (g) in the axonal compartment during 60 min from the control (Ctl) and MSC-exosome (Exo) groups. Yellow and red arrows in f indicate starting (0 min) and ending (60 min) points, respectively. The representative time-lapse microscopic images (f) were acquired from 24 h after soma application of the exosomes, whereas quantitative data (g) were acquired for 24 and 48 h after exosome application. *p < 0.05 vs control. Sample size in g represents the number of the growth cone from every independent experiment (color figure online) following primary antibodies were used to detect proteins in exosomes: mouse monoclonal anti-Alix (1:500; Cell Signaling), rabbit polyclonal anti-Hsp70 (1:500, Abcam), and rabbit polyclonal anti-VAMP2 (1:500, ab3347, Abcam).
Isolation of Total RNA and Real-Time Reverse Transcriptase-Polymerase Chain Reaction
To analyze miRNAs, total RNA was isolated using the miRNeasy Mini kit (Qiagen, Valencia, CA, USA). Quantitative RT-PCR was performed on an ABI 7000 and ABI ViiA™ 7 PCR instrument (Applied Biosystems, Foster City, CA). miRNAs were reversely transcribed with the miRNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) and amplified with the TaqMan miRNA assay (Applied Biosystems), which is specific for mature miRNA sequences. The following specific primers were used: miR-17 (mature sequence CAAAGUGCUUAC A G U G C A G G U A G ) , m i R -1 8 a ( m a t u r e s e q u e n c e UAAGGUGCAUCUAGUGCAGAUAG), miR-19a (mature sequence UGUGCAAAUCUAUGCAAAACUGA), miR-1 9 b ( m a t u r e s e q u e n c e U G U G C A A A U C C A U G C AAAACUGA), miR-20a (mature sequence UAAAG UGCUUAUAGUGCAGGUAG), miR-92 (mature sequence UAUUGCACUUGUCCCGGCCUG), and U6 snRNA (mature sequence GTGCTCGCTTCGGCAGCACATAT ACTAAAATTGGAACGATACAGAGAAGATTAGCATG-GCCCCTGCGCAAGGATGACACGCAAATTCGTGAAG-CGTTCCATATTTT). Analysis of gene expression was carried out by the 2 −ΔΔCt method [38] .
Statistical Analysis
All statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, version 11.0; SPSS Inc., Chicago, IL). One-way ANOVA with post hoc Bonferroni tests was used when comparing more than two groups. Student's t test was used when comparing two groups. Values presented in this study are expressed as mean ± standard error of the mean (SEM). A p value <0.05 was considered to be significant.
Results

Exosomes Derived from MSCs Promoted Axonal Growth
To examine the effect of exosomes on axonal growth, we isolated exosomes from cultured MSCs. MSC-exosomes had a mean diameter of 104 nm ( Fig. 1) and Western blot analysis showed that these exosomes contained Alix and Hsp70 proteins, markers of exosomes ( Fig. 1) , which are consistent with MSC-exosome characteristics [24] . We found that exosomes applied to the cell body compartment significantly increased length of the distal axons by 33 and 24 % at 24 and 48 h in culture, respectively, compared to the distal axons of cortical neurons cultured without exosomes (Fig. 1d, e) . To further examine the soma application of exosomes on promoting axonal growth, axonal growth of the cultured neurons treated with or without exosomes for 24 and 48 h was monitored in real time by means of the time-lapse microscopy. During a 60-min observation period, we detected that the speed of distal axonal elongation was 13 ± 2 μm/h and 13 ± 1 μm for neurons treated with exosomes for 24 and 48 h, respectively, whereas the axonal elongation in the neurons without treatment with exosomes occurred at the speed of 8±1 and 10±1 μm/h for these two time points (p < 0.001, Fig. 1f, g ). Collectively, these data demonstrated that application of MSCs-derived exosomes into cell bodies of cortical neurons promotes distal axon growth. We then examined whether axonal application of naïve MSC-exosomes locally increases axonal growth. In preliminary experiments, we found that axonal application of the ) and within pNFH+ growth cone (c, red) after axonal application of the Exo-fect® labeled naive MSC-exosomes (b, c, Exo), whereas green fluorescent signals were randomly distributed apart from the pNFH+ distal axon (e, green) after the axonal application of Exo-fect® labeled MSC-exosomes pretreated with BoNT/B (e, Exo BoNT/B). The white dash line outlines contours of cell bodies, axons, and a growth cone. Each image was a composite image from 5 Z stack images at 0.5-μm interval on the growth cone area or 10 Z stack images at 0.5-μm interval on the cell body area, respectively (color figure online) exosomes at a concentration of 3 × 10 9 particles/ml induced axonal damage including axonal retraction, while concentrations of 3 × 10 7 and 3 × 10 8 particles/ml did not cause axonal damage. Thus, a concentration of 3 × 10 8 particles/ml was employed to axonal application of exosomes in the following experiments. Unlike the soma application of exosomes, the application of exosomes into the axonal compartment for 24 h did not significantly increase distal axonal growth (341 ± 14 vs 297 ± 9 μm in control group, p > 0.05, n = 6). However, the axonal application of exosomes for 48 h significantly (p < 0.001) increased length of distal axons (Fig. 2a) . Timelapse microscopic experiments showed that the axonal application of exosomes for 48 h increased the speed of distal axonal elongation by 50 % (p < 0.05), from 10 ± 1 μm/h in the control group to 15 ± 2 μm/h in the exosome group (Fig. 2b-d) . These data indicate that in addition to cell bodies, the axonal application of exosomes locally regulates axonal growth.
The SNARE Complex Is Required for Neuronal Internalization of MSC-Exosomes
To examine whether exosomes enter into neurons, we tracked MSC-exosomes transfected with fluorescently labeled siRNA in cultured cortical neurons. The transfected exosomes were added into the cell body or the axonal compartment. The neurons and distal axons were imaged 24 h after application of the exosomes by means of a confocal microscope. For the cell body application of labeled exosomes, the fluorescent particles were detected in the cytoplasm of neurons, whereas fluorescent signals were not detected in the axonal compartment (Fig. 3a) . For the axonal application, fluorescent particles were only found in the axonal compartment and fluorescent signals were localized along the axons and within the growth cones (Fig. 3b) . These data suggest that the cortical neurons internalize MSC-exosomes.
SNARE proteins regulate the synaptic vesicle transcytosis [33, 39] . BoNT/B is responsible for synaptobrevin-2, VAMP2, cleavage, whereas BoNT/A cleaves a peripheral plasma membrane protein SNAP25 [40, 41] . Western blot analysis of MSCexosomes and cortical neurons revealed that the exosomes contained VAMP2 proteins, while neurons expressed SNAP-25 (Fig. 4b) . To examine whether SNARE proteins are involved in the observed exosome internalization, exosomes were pretreated with BoNT/B and then were applied into the cell body or the axonal compartment. Compared to exosomes without pretreatment, BoNT/B-pretreated exosomes placed in either the cell body or the axonal compartment did not increase axonal growth (Fig. 4a) , Moreover, confocal microscopic analysis revealed that BoNT/B-pretreated exosomes identified by fluorescent particles were randomly distributed in the somal or the axonal compartments of the microfluidic culture device and that few of them were detected within the neuronal cytoplasm and axons (Fig. 3c) . MSC-exosomes treated with BoNT/B exhibited significant reduction of VAMP2, whereas BoNT/B pretreatment did not affect Alix protein levels in exosomes compared to nontreatment (Fig. 4b) , suggesting that BoNT/B specifically acts on VAMP2.
We then examined the effect of BoNT/A on neuronal internalization of MSC-exosomes. Pre-soma application of BoNT/A (500 nM) for 24 h significantly blocked exosome-increased axonal growth compared to the axonal application of exosomes only (Fig. 4c) . Preaxonal application of BoNT/A (100 nM) also abolished the effect of the soma application of exosomes on increased axonal growth (Fig. 4c) . The time-lapse microscopic analysis showed that preapplication of BoNT/A either to the soma compartment or the axonal compartment substantially (p < 0.05) reduced the speed of growth cone extension increased by exosomes (Fig. 4d) . Western blot analysis revealed that preapplication of BoNT/A itself either into the soma or the axonal compartment robustly reduced SNAP25 proteins in the somata and axons (Fig. 4e, f) . However, BoNT/A itself did not significantly affect axonal growth but robustly reduced uptake of FM 1-43 FX dye in growth cone (Fig. 4g, h ), suggesting that BoNT/A affects endocytosis. Collectively, these data suggest that SNARE proteins participate the process of exosome internalization into axons and cytoplasm of cortical neurons.
To exclude the possibility that exosome-enhanced axonal growth is induced by extra-exosomal cellular RNAs, exosomes were treated with RNase A that digests extra-exosomal cellular RNAs but preserves RNAs within exosomes [42] . Application of exosomes treated with RNase A (1 μg/ml) into the soma or the axonal compartment for 24 or 48 h, respectively, significantly increased axonal growth compared to the controls (442 ± 14 vs 297 ± 9 μm in control for the soma and 670 ± 32 vs 505 ± 16 μm in control for the axon, p < 0.05, n = 3/group), which was comparable to applications of the naïve exosomes. We then sonicated exosomes for 10 s to destroy exosomes. The effect of exosomes on enhancement of axonal growth was abolished when sonicated exosomes were applied either to the soma or the axonal compartment for 24 (305 ± 23 vs 297 ± 9 μm in control group, p > 0.05, n = 3) or 48 h (297 ± 12 vs 297 ± 9 μm in control group, p > 0.05, n = 3), respectively. These data suggest that RNAs and proteins within MSC exosomes play a role in exosome-increased axonal growth.
Ago2 Is Required for Exosome-Promoted Axonal Growth
Ago2 protein, a component of the RNA-induced silencing complex (RISC), is the key regulator of miRNA function by mediating the activity of miRNA-guided mRNA cleavage or translational inhibition [43, 44] . Exosomes contain Ago2 [30, 31, 45] . Consistent with published data, our Western blots showed the presence of Ago2 protein in MSC-exosomes (Fig. 5a ). We then examined whether Ago2 is involved in the exosome-increased axonal growth by reduction of Ago2 in exosomes. MSCs were transfected with siRNA-Ago2 and exosomes were harvested from supernatant of these MSCs. Western blot analysis revealed that compared to transfection with scramble probes, siRNA-Ago2 transfection substantially reduced Ago2 proteins in MSCs and nearly abolished Ago2 in exosomes (Fig. 5a ), indicating that transfection effectively suppresses Ago2 expression. As expected, application of exosomes from the MSCs transfected with scramble siRNA into the soma compartment promoted axonal growth. However, the soma application of Ago2-reduced exosomes did not significantly increase axonal growth (Fig. 5b, c) . These data suggest that Ago2 in MSC-exosomes is required for exosome-increased axonal growth.
miRNAs within exosomes are bound to Ago2 [30] . To examine whether reduction of Ago2 levels in exosomes affects miRNA content, miRNA array analysis was performed. Compared to miRNAs within exosomes from MSCs transfected with scramble siRNAs, approximately 76 % of miRNAs were reduced in Ago2-reduced exosomes ( Table  1 ), suggesting that exosomes may deliver miRNAs into the axon, mediating exosome-increased axonal growth.
Exosomes with Elevated miR-17-92 Cluster Further Promote Axonal Growth
We then examined the effect of tailored exosomes with elevation of the miR-17-92 cluster on axonal growth based on published studies showing that the miR-17-92 cluster regulates axonal growth [16] . MSCs were transfected with a miR-17-92 cluster plasmid or an empty vector. Exosomes were then harvested from supernatant of these MSCs. Quantitative realtime RT-PCR analysis of the harvested exosomes showed that levels of all individual six members of the miR-17-92 cluster were increased within exosomes isolated from MSCs transfected with the miR-17-92 cluster (miR-17-92-exosomes) compared to levels within exosomes from MSCs transfected with the empty vector (empty-vector-exosomes, Fig. 6a) . Application of the empty-vector-exosomes into the soma compartment significantly increased axonal growth, compared to without exosome treatment, which was comparable to naive exosome-enhanced axonal growth (Fig. 6b, c) . These data suggest that transfection itself did not affect exosome-increased axonal growth. However, compared to the empty-vector-exosomes, the miR-17-92-exosomes increased axonal growth by 47 % (p < 0.001, Fig. 6b, c) . The time-lapse microscopic analysis showed that the miR-17-92-exosomes increased axonal growth speed (17 ± 2 μm/h, n = 43 axons, vs 13 ± 1 μm/h, n = 44 axons, for the empty-vectorexosomes, p < 0.05) (Fig. 6d) . Consistent with soma application of the tailored exosomes, axonal application of the miR17-92-exosomes also significantly increased axonal elongation and axonal growth speed compared to the axonal application of the empty-vector-exosomes (Fig. 6e, f) .
To examine whether elevated miR-17-92 cluster in exosomes affects the cluster levels in recipient neurons and axons, levels of individual members of the cluster were measured. Quantitative real-time RT-PCR analysis showed that soma application of the miR17-92-exosomes significantly increased levels of individual members of the cluster in the recipient neurons and axons (Fig. 7a) . Furthermore, Western blot analysis showed that levels of PTEN, one of validated targets by the miR-17-92 cluster, were substantially reduced in the neurons and axons treated with the naïve or the emptyvector-exosomes compared to the nonexosome treatment (Fig. 7b, c) . Treatment with the miR-17-92-exosomes further decreased the PTEN levels in neurons and axons compared to the empty-vector-exosome treatment (Fig. 7b, c) . Reduction of PTEN protein in neurons and axons was associated with elevation of phosphorylated mTOR and GSK-3β proteins, two well-known PTEN downstream proteins (Fig. 7b, c) . Collectively, these data indicate that exosomes deliver the 
Exosomes with Elevated miR-17-92 Overcome the Inhibitory Effect of CSPGs
The extracellular matrix inhibitory effect on axonal growth evoked by brain injury is the major obstacle for the regeneration of axons [46] [47] [48] . CSPGs expressed by glial cells are inhibitory factors present after injury [49] . We previously found miRNAs in axons modulate the inhibitory effect of CSPGs [23] . Since we demonstrated that the miR-17-92 cluster within tailored enriched miR-17-92 exosomes is delivered into axons, we assessed whether MSC-exosomes overcome the inhibition of CSPGs on axonal growth. We found that 2 μg/ml CSPGs applied into the axonal compartment significantly inhibited axonal growth by 36 % (p < 0.05, Fig. 8a ). As we expected, the application of naive or empty-vector-exosomes into the soma compartment for 24 h reversed the inhibition caused by CSPGs, respectively. Moreover, the miR-17-92-exosomes showed substantially enhanced promotion of axonal growth under CSPG conditions (p < 0.05, Fig. 8a, Soma) . Similarly, application of naive or empty-vector-exosomes into the axonal compartment for 48 h also reversed the CSPG inhibitory effect on axonal growth. Addition of the miR-17-92-exosomes into the axonal compartment further enhanced the axonal growth under CSPG conditions by 38 % (p < 0.05, Fig. 8a, Axon) . The time-lapse microscopic analysis also showed that the miR-17-92-exosomes substantially increased axonal growth speed under CSPG condition either when they were applied into the soma compartment for 24 h (13 ± 2 μm/h, n = 40 axons, vs 4 ± 1 μm/h, n = 42 axons, for CSPG-treated axons, p < 0.05) (Fig. 8b) or applied into the axonal compartment for 48 h (14 ± 2 μm/h, n = 35 axons, vs 5 ± 1 μm/h, n = 41 axons, for CSPGtreated axons, p < 0.05) (Fig. 8c) . Together, these data demonstrated that the naive and tailored MSC-exosomes overcome the CSPG inhibitory effect on axonal growth, whereas tailored exosomes further enhanced the growth. 
Discussion
The present study demonstrates that exosomes derived from MSCs promoted axonal growth of cultured cortical neurons. Internalization of MSC-exosomes into neurons and distal axons was mediated by SNARE complex. Reduction of Ago2 in MSC-exosomes abolished exosome-promoted axonal growth. Importantly, tailored MSC-exosomes with elevated miR-17-92 cluster further enhanced axonal growth via the PTEN/mTOR signals in the neurons, when the exosomes were applied into the soma or axonal compartments even under the CSPG inhibitory environment. These data suggest that MSC-derived exosomes communicate with cortical neurons to enhance axonal growth by transferring biological materials, in particular miRNAs, which provides not only new insights into molecular mechanisms underlying axonal remodeling enhanced by MSC cell therapy, but also proof of principle for exosomes as cargo to deliver specific miRNAs into axons of the cortical neurons. Cellular and molecular mechanisms underlying MSC therapy to enhance neurological outcomes after brain injury are not fully understood, although it is known that treatment of the injured brain with MSCs stimulates endogenous brain repair processes [50] [51] [52] [53] [54] . The present study demonstrated that exosomes derived from MSCs promoted axonal growth of the cortical neurons, suggesting that exosomes released from grafted MSCs could communicate with endogenous neurons in injured brain to enhance axonal growth. Indeed, we recently showed that intravenous administration of MSC-exosomes to animals subjected to stroke or TBI enhanced brain repair and improved neurological function at the levels that are comparable to the MSC therapy [22, 23] . Others have shown that exosomes derived from myelinating cells, oligodendrocytes, and Schwann cells communicate with cortical and dorsal root ganglia (DRG) neurons, respectively, to regulate axonal function [55, 56] .
Exosomes contain biomaterials including proteins, DNAs, RNAs, and miRNAs. Using several approaches, the present study demonstrated that miRNAs within MSC-exosomes mediate MSC-exosome enhanced axonal growth. The catalytic activity of Ago2 in miRNA RISC regulates biological function of mature miRNAs by cleaving the target mRNAs [57] . Ablation and overexpression of Ago2 decreases and increases, respectively, the miRNA stability [58] . MiRNAs within exosomes are bound to Ago2 and knockout of Ago2 leads to decrease of miRNA abundance within exosomes [30] . Consistent with those published studies, we found that MSC-exosomes contained Ago2. Reduction of Ago2 protein within the exosomes resulted in decrease of exosomal miRNAs and abolished MSC-exosome promoted axonal growth. In addition, the present study demonstrated that tailored exosomes carrying elevated miR-17-92 cluster can further enhance axonal growth even in the presence of the extracellular CSPG inhibitors compared to naive MSC-exosomes, which is likely caused by interactions between the miR-17-92 cluster within the exosomes and its target gene, PTEN, within recipient neurons. We have shown that the miR-17-92 cluster within distal axons of cortical neurons locally promotes axonal growth by targeting PTEN/mTOR signals [16] . Others also demonstrate that miR-338 [59] , miR-132 [13] , miR-9 [60] , and miR-8 [61] are enriched in distal axons and regulate their target genes involving energy metabolism and cytoskeleton function leading to modulating axonal growth. Distal axons contain miRNA machinery proteins [13, 16, 59, 60] . The PTEN/mTOR signaling pathway has been demonstrated to mediate axonal growth after CNS injury [62, 63] . CSPGs show protein levels of PTEN, mTOR, pGSK-3β in somata (c) and distal axons (d) after treatment with naive exosomes (Naive), empty vector exosomes (Empty) and miR-17-92 cluster enriched exosomes (miR-17-92), when exosomes were applied into the soma compartment. *p < 0.05 vs control group; #p < 0.05 vs miR-17-92 group block axonal sprouting in ischemic brain [46, 64, 65] . The present study suggests that activation of intrinsic axon growth signals by tailored exosomes carrying elevated miR-17-92 cluster can overcome an inhibitory extrinsic environment. Thus, tailored exosomes carrying specific miRNAs that mediate axonal growth have enormous therapeutic potential to enhance axonal growth.
The present study showed that compared to the axonal growth increased by the cell body treatment, the axonal application of MSC-exosomes required an additional 24 h to augment axonal growth, although the exosomes were internalized by the cell bodies and axons 24 h after the cell body and distal axon applications of the exosomes, respectively. The cause of this delay is currently unknown. Other than the local storage of mRNAs in distal axon, mRNAs via RNA-binding proteins are transported from the cell body to the axon in response to the extracellular signals [66] [67] [68] . We speculate that in addition to interaction with local genes in the distal axon, miRNAs delivered by the exosomes into distal axons may retrogradely communicate with genes in the cell body, leading to transport of proteins from the cell body to the distal axons and thereby increasing axonal growth. Exosomes are membrane vesicles and can be internalized by recipient cells [69, 70] . Endocytosis is one of the major routes that mediate exosome internalization by recipient cells [69, 71] . Factors that regulate endocytosis including clathrin [71] , caveolae [72] , lipid raft [73] , and macropinocytosis [74] affect exosomal internalization by recipient cells. Protein interactions between exosomes and recipient cells are required for exosomal internalization. For example, when exosomes are treated with proteinase K, the uptake of the exosomes is substantially reduced by ovarian cancer cells [75] . The SNARE complex acts as the regulator for the vesicle exocytosis at the presynaptic compartment and mediates the docking and fusion of vesicles to membrane compartments, which lead to the release of the neurotransmitter into the synaptic cleft after an action potential [33, 76] . Recent studies found that two major components which assemble SNARE complex, synaptobrevin/VAMP at the vesicle membrane and SNAP25 at the plasma membrane, also modulate the vesicle endocytosis at synapses, indicating a dual role of SNARE complex on vesicle transport [39, 77] . The present study demonstrated that cleavage of VAMP2 in MSCexosomes and cleavage of SNAP-25 in cortical neurons blocked of internalization of MSC-exosomes, indicating that the SNARE complex mediates neuronal uptake of MSCexosomes. Our unpublished data showed that VAMP2 was not present in exosomes isolated from cerebral endothelial cells. Additional studies are warranted to examine whether the SNARE complex regulates neuronal uptake of exosomes is specific to MSC-exosomes. 
